This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...